Clinical trial
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable…
NCT00173875 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00173875 |
|---|---|
| Title | Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer |
| Official title | A Phase II Study to Evaluate the Efficacy and Safety of Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Iressa |
| Enrollment | 108 |
| Start date | Mar 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 30, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: